CMS INDUSLAW and Anagram Partners advised Hindustan Unilever on the acquisition of OZiva for INR 8.24 billion.
Hindustan Unilever Limited (HUL) has acquired the remaining 49% equity stake in Zywie Ventures Private Limited (OZiva), taking its total holding to 100%, for a cash consideration of INR 8.24 billion.
HUL had previously acquired a 51% stake in Zywie in 2023 as part of its strategic entry into the high-growth Health & Wellbeing segment.
Zywie is a leading plant-based nutrition and wellness brand, offering clean, science-backed products across categories such as women’s health, skin, hair, and general wellbeing.
CMS INDUSLAW acted as legal adviser to Hindustan Unilever Limited on the transaction, including corporate and intellectual property matters, with strategic inputs from Founding & Senior Partner Avimukt Dar.
The corporate team comprised Principal Associate Shivani Singh, Associates Rusha Ghosh Dastidar, and Prakhar Srivastava. The IP team comprised Partner Bharadwaj Jaishankar, Senior Associate Trushita Mehra, and Associate Ishita Goyal.
Past team members also contributed during their tenure at CMS INDUSLAW.
Anagram Partners advised HUL on the acquisition of 49% stake in Zywie (OZiva).
The team was led by Partner Harman Walia, with Sanjana Mathur, Tanmaya Negi, Aman Gupta, and Aditi Sinha.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
